Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid,colecalciferol, Date of authorisation: 16/10/2009, Revision: 20, Status: Authorised

Submitted by Anonymous (not verified) on 18 July 2024 - 14:28

Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid,colecalciferol, Date of authorisation: 16/10/2009, Revision: 20, Status: Authorised

Quarterly System Demo – Q2 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 09:00 (CEST) to 26 June 2024, 13:30 (CEST)

Submitted by Anonymous (not verified) on 18 July 2024 - 13:02

Quarterly System Demo – Q2 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 09:00 (CEST) to 26 June 2024, 13:30 (CEST)

Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised

Submitted by Anonymous (not verified) on 18 July 2024 - 10:26

Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised

Committee for Orphan Medicinal Products (COMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024

Submitted by Anonymous (not verified) on 17 July 2024 - 15:23

Committee for Orphan Medicinal Products (COMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness